Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 18, 2018

Posted on: 11 Jan 18

BURLINGTON, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham & Company’s 20th Annual Growth Conference on Thursday, January 18, 2018 at the Lotte New York Palace Hotel in New York, NY.

The Company is scheduled to present at 8:00 a.m. EST.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at

Contact:  LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames


Last updated on: 15/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.